文献速递临床微生物质量管理与危急值分子诊断

微生物实验室诊断管理认知与实践:美国微生物学会全国调查

Diagnostic stewardship perceptions and practices among microbiology laboratories: a national survey from the American Society for Microbiology.
PubMed 文献 · J Clin Microbiol · 2026-06-22

该研究对美国临床微生物学家进行全国调查,119名受访者中50.4%表示其机构有时开展诊断管理(DxS),23.5%表示大部分时间开展。学术医学中心实验室比社区医院实验室更常报告拥有微生物会诊服务、DxS/实验室利用委员会或官方实验室处方集(P ≤ 0.001)。最大挑战是时间和人力资源(52.1%),最有效策略是信息技术(78.2%)。

要点

  • 诊断管理在微生物实验室开展频率有限,仅23.5%受访者称大部分时间开展。
  • 学术医学中心实验室比社区医院更常具备DxS相关委员会和会诊服务(P ≤ 0.001)。
  • 信息技术被认为最有效策略(78.2%),时间和人力资源是最大挑战(52.1%)。

核心结论

  • 诊断管理在临床微生物实验室的实践尚不普遍,学术医学中心与社区医院存在显著差异。

研究设计与样本

  • 美国微生物学会发起的全国性调查,共119名受访者(83名临床主任、33名运营负责人、3名培训生)。

主要发现

  • 50.4%受访者表示其机构有时开展DxS,23.5%表示大部分时间开展。
  • 学术医学中心实验室更常报告拥有微生物会诊服务、DxS/实验室利用委员会或官方实验室处方集(P ≤ 0.001)。
  • 感染病提供者(79.0%)和临床实验室主任(74.8%)是最常见DxS参与者。
  • 信息技术被认为最有效策略(78.2%),抗菌药物管理和/或感染病协作是最有价值资源(52.1%)。
  • 最大挑战是时间和人力资源(52.1%);分子检测(22.7%综合征 Panel、21.0%测序)是DxS优先事项。

关键数值与推荐

  • 学术医学中心实验室与其他受访者相比更可能将测序检测视为最高优先级(P < 0.001)。

临床怎么用

  • 微生物实验室可优先利用信息技术工具并加强与感染病提供者协作以推进诊断管理。
  • 学术医学中心可发挥其委员会和会诊服务优势,社区医院需关注资源限制。

局限性

  • 调查基于受访者自我报告,可能存在回忆偏倚。
  • 样本量有限(119人),代表性可能受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Diagnostic stewardship (DxS) is a key activity for providing effective and efficient testing strategies for patient care. Complex test menus and result interpretation, high costs, limited reimbursements, and other factors necessitate DxS practices in clinical microbiology. We conducted a national survey of clinical microbiologists on their perceptions and practice of DxS in infectious diseases (ID) diagnostics. The 119 respondents (83 clinical directors, 33 operational leaders, and three trainees) indicated that DxS was practiced at their institution "some" (50.4%) or "most" (23.5%) of the time. Most respondents (>95%) had infection prevention and control and antimicrobial stewardship committees at their institutions. Academic medical center laboratories (AMCs) more often reported having microbiology consultation service, DxS/laboratory utilization committee, or official laboratory formulary than community hospital laboratories (P ≤ 0.001). Respondents identified ID providers (79.0%) and clinical laboratory directors (74.8%) as the most common participants in their DxS activities. Leveraging informational technology (IT) was considered the most effective strategy (78.2%), and antimicrobial stewardship and/or ID collaboration (52.1%) was the most valuable resource for supporting DxS. The biggest challenge was time and personnel resources (52.1%). Respondents highlighted molecular testing, including syndromic panels (22.7%) and sequencing-based assays (21.0%), as a top priority for DxS efforts, followed by culture-based testing (20.2%). AMC respondents more likely considered sequencing assays as highest priority than other respondents (P < 0.001). These data provide a valuable baseline for understanding the state of DxS in clinical microbiology laboratories. Key challenges include personnel resources and opportunities include engaging with ID providers and utilization of IT tools for DxS initiatives. IMPORTANCE: At a time when microbiology test menus are expanding with costly molecular diagnostics while workforce shortages and reimbursement constraints persist, we conducted a national survey-based study of clinical microbiology professionals to capture their perceptions and practice of diagnostic stewardship. Results from 119 clinical microbiologists identified several common challenges as well as key differences between respondents from different institutional types as well as between respondents fulfilling different professional roles. The survey additionally identified diagnostic stewardship interventions regarded as most effective, factors most important in prioritization of stewardship efforts, and breadth of roles participating in diagnostic stewardship for microbiology tests. These unique observations into the state of diagnostic stewardship in clinical microbiology laboratories help establish a baseline for future research and guideline development in infectious disease testing.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. She RC, Larkin P, Parrott JS, et al. Diagnostic stewardship perceptions and practices among microbiology laboratories: a national survey from the American Society for Microbiology. J Clin Microbiol. 2026. PMID: 42324607. doi:10.1128/jcm.00239-26

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。